K-ATP Channels: Another Link Between Type 1, 2, and Neonatal Diabetes Researching causes of early embryonic developmental diseases like neonatal diabetes may elucidate our understanding…
How do we progress from revolutionary bench science discoveries to clinically translatable therapeutics and techniques? In silico methods seek to leap over these foundational hurdles…
Planting the Seed By: James LeFevre and Neha Majety Embryonic stem cell treatment is a promising method of treating and potentially curing type 1 diabetes…
Gee whiz: HLA-G in placental development and pancreatic islet transplantation By: Shruthi Kandalai Islet cell transplantation, or transplanting insulin-producing islet cells from donors into patients,…
Shields Up: lessons from placental genetics to avoid immune attack on islet transplants By: Shruthi Kandalai Islet cell transplantation, or transplanting insulin-producing islet cells from…
stem cell therapy: current developments applied to t1d By: Alex Parrott and James LeFevre Stem cells are an incredibly useful and versatile tool to treat…
Born to be a “Natural Killer”: Understanding the Role of Natural Killer Cells and Galectins in Maternal Immune Response By: Neha Majety During pregnancy, a…
Protecting Transplanted Islets: Engineering Materials for Islet Tissue Transplantation By: Tiffany Richardson and Rachel Gurlin To mitigate the biological and lifestyle impacts of constant insulin…
Extracellular Vesicles and Islet Transplantation Strategies By: Zach Jones What is Islet Transplantation? Type 1 diabetes (T1D) is characterized by the autoimmune destruction of insulin-producing…
What Makes the Placenta So Tough? Placental Factors in Immunomodulation By: Hadeel Saab and Mari Yamamoto Immune checkpoint molecules (such as CTLA-4, TIM-3 and PD-1) work…
